The purpose of this study is to evaluate efficacy and safety of CKD-351
Multi center, Randomized, Open-label, Active controlled, Phase 2 trial, Proof Of Concept Study to evaluate the efficacy and safety of CKD-351 in primary open angle glaucoma or ocular hypertension patients
| Condition | EYE DISORDER, Eye Disorders/Infections, Eye Disorders/Infections (Pediatric), Dry Eye Disease, Eye Disease, Ocular Hypertension, Ocular Hypertension, Glaucoma, Glaucoma, Pigmentary glaucoma, Open Angle Glaucoma, Eye Disorders/Infections, Dry Eye Disease, Primary Open Angle Glaucoma, Eye Disorders/Infections (Pediatric), Eye Disease, Open Angle Glaucoma |
|---|---|
| Treatment | CKD-351, Latanoprost+Dorzolmamide |
| Clinical Study Identifier | NCT04448223 |
| Sponsor | Chong Kun Dang Pharmaceutical |
| Last Modified on | 4 February 2023 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.